Ameriprise
BSX icon

Ameriprise’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$838M Sell
7,786,959
-64,744
-0.8% -$6.97M 0.21% 105
2025
Q1
$792M Sell
7,851,703
-254,065
-3% -$25.6M 0.21% 97
2024
Q4
$724M Sell
8,105,768
-100,157
-1% -$8.95M 0.19% 112
2024
Q3
$688M Buy
8,205,925
+306,315
+4% +$25.7M 0.18% 125
2024
Q2
$608M Buy
7,899,610
+1,824,405
+30% +$140M 0.16% 135
2024
Q1
$416M Sell
6,075,205
-1,449,424
-19% -$99.3M 0.11% 194
2023
Q4
$435M Buy
7,524,629
+2,165,709
+40% +$125M 0.13% 173
2023
Q3
$283M Sell
5,358,920
-2,565,258
-32% -$135M 0.09% 223
2023
Q2
$429M Sell
7,924,178
-1,741,971
-18% -$94.2M 0.13% 166
2023
Q1
$484M Sell
9,666,149
-82,520
-0.8% -$4.13M 0.16% 145
2022
Q4
$451M Sell
9,748,669
-272,316
-3% -$12.6M 0.15% 147
2022
Q3
$388M Buy
10,020,985
+1,054,619
+12% +$40.8M 0.14% 158
2022
Q2
$334M Buy
8,966,366
+7,454,042
+493% +$278M 0.12% 194
2022
Q1
$66.6M Sell
1,512,324
-506,366
-25% -$22.3M 0.02% 678
2021
Q4
$85.6M Buy
2,018,690
+189,647
+10% +$8.04M 0.02% 624
2021
Q3
$79.4M Sell
1,829,043
-252,776
-12% -$11M 0.03% 586
2021
Q2
$89M Buy
2,081,819
+270,550
+15% +$11.6M 0.03% 567
2021
Q1
$70M Buy
1,811,269
+8,572
+0.5% +$331K 0.02% 626
2020
Q4
$64.8M Sell
1,802,697
-3,114,695
-63% -$112M 0.02% 628
2020
Q3
$188M Buy
4,917,392
+397,577
+9% +$15.2M 0.08% 263
2020
Q2
$159M Buy
4,519,815
+1,965,964
+77% +$69M 0.07% 284
2020
Q1
$83.3M Buy
2,553,851
+179,884
+8% +$5.87M 0.04% 382
2019
Q4
$107M Sell
2,373,967
-27,587
-1% -$1.25M 0.04% 398
2019
Q3
$97.6M Buy
2,401,554
+251,879
+12% +$10.2M 0.04% 412
2019
Q2
$92.4M Sell
2,149,675
-28,909
-1% -$1.24M 0.04% 445
2019
Q1
$83.6M Buy
2,178,584
+128,585
+6% +$4.93M 0.04% 472
2018
Q4
$72.4M Buy
2,049,999
+279,585
+16% +$9.88M 0.04% 482
2018
Q3
$68.4M Buy
1,770,414
+88,801
+5% +$3.43M 0.02% 590
2018
Q2
$55M Sell
1,681,613
-340,214
-17% -$11.1M 0.02% 632
2018
Q1
$55.2M Buy
2,021,827
+63,689
+3% +$1.74M 0.03% 602
2017
Q4
$48.5M Sell
1,958,138
-142,557
-7% -$3.53M 0.02% 598
2017
Q3
$61.3M Buy
2,100,695
+193,710
+10% +$5.65M 0.03% 500
2017
Q2
$52.9M Buy
1,906,985
+387,611
+26% +$10.7M 0.03% 536
2017
Q1
$37.8M Sell
1,519,374
-152,628
-9% -$3.79M 0.02% 657
2016
Q4
$36.2M Buy
1,672,002
+595,032
+55% +$12.9M 0.02% 657
2016
Q3
$25.6M Sell
1,076,970
-1,482,466
-58% -$35.3M 0.01% 787
2016
Q2
$59.8M Sell
2,559,436
-1,557,544
-38% -$36.4M 0.04% 429
2016
Q1
$77.4M Sell
4,116,980
-212,336
-5% -$3.99M 0.05% 371
2015
Q4
$79.8M Buy
4,329,316
+364,201
+9% +$6.72M 0.05% 352
2015
Q3
$65.1M Buy
3,965,115
+2,315,265
+140% +$38M 0.04% 392
2015
Q2
$29.2M Sell
1,649,850
-1,344,718
-45% -$23.8M 0.02% 766
2015
Q1
$53.1M Buy
2,994,568
+2,392,639
+397% +$42.5M 0.03% 508
2014
Q4
$7.98M Buy
601,929
+24,152
+4% +$320K ﹤0.01% 1700
2014
Q3
$6.82M Sell
577,777
-575,510
-50% -$6.8M ﹤0.01% 1796
2014
Q2
$14.7M Sell
1,153,287
-63,088
-5% -$806K 0.01% 1245
2014
Q1
$16.4M Sell
1,216,375
-4,985,932
-80% -$67.4M 0.01% 1142
2013
Q4
$74.6M Sell
6,202,307
-3,932,261
-39% -$47.3M 0.05% 389
2013
Q3
$119M Sell
10,134,568
-886,902
-8% -$10.4M 0.08% 273
2013
Q2
$102M Buy
+11,021,470
New +$102M 0.07% 314